Cargando…

Impact of therapeutic drug level monitoring on outcomes of patients with Crohn’s disease treated with Infliximab: real world data from a retrospective single centre cohort study

BACKGROUND: Therapeutic drug monitoring (TDM) by measuring infliximab (IFX) trough levels and antibodies to infliximab (ATI) is used to optimise treatment in inflammatory bowel disease. We aimed to explore the clinical outcomes of TDM for patients with Crohn’s disease on IFX in real life setting. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamperidis, Nikolaos, Middleton, Paul, Tyrrell, Tracey, Stasinos, Ioannis, Arebi, Naila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Colorectal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788274/ https://www.ncbi.nlm.nih.gov/pubmed/31682652 http://dx.doi.org/10.1136/flgastro-2018-101024

Ejemplares similares

A practical guide to thiopurine prescribing and monitoring in IBD
por: Warner, Ben, et al.
Publicado: (2018)

Stratification of inflammatory bowel disease outpatients by disease activity and risk of complications to guide out-of-hospital monitoring: a patient-centred quality improvement project
por: Fofaria, Rishi K, et al.
Publicado: (2019)

Survival outcomes after synchronous para‐aortic lymph node metastasis in colorectal cancer: A systematic review
por: Aylward, Conor, et al.
Publicado: (2022)

Disease monitoring of biologic treatment in IBD: early impact and future implications of COVID-19 pandemic
por: Shields, Stephanie, et al.
Publicado: (2020)

Acceptability of a ‘treat to target’ approach in inflammatory bowel disease to patients in clinical remission
por: Selinger, Christian, et al.
Publicado: (2020)

Diverticular Disease Complicated With Colovesical Fistula: Laparoscopic Versus Robotic Management
por: Maciel, Victor, et al.
Publicado: (2014)

Benefit of Oral Feeding as Early as One Day After Elective Surgery for Colorectal Cancer: Oral Feeding on First Versus Second Postoperative Day
por: Fujii, Takaaki, et al.
Publicado: (2014)

Ileosigmoid Knot at Week 13 of Pregnancy: Report of a Case
por: Shimizu, Riha, et al.
Publicado: (2014)

The molecular genetics of colorectal cancer
por: Ewing, Iain, et al.
Publicado: (2014)

Value of drug level testing and antibody assays in optimising biological therapy
por: Vermeire, Séverine, et al.
Publicado: (2013)

Laparoscopic Sigmoidectomy for a Patient With Situs Inversus Totalis: Effect of Changing Operator Position
por: Yaegashi, Mizunori, et al.
Publicado: (2015)

Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
por: Dhaliwal, A, et al.
Publicado: (2015)

Passage of a Sigmoid Colon Cast in a Patient With Ischemic Colitis
por: Abe, Shinya, et al.
Publicado: (2014)

Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome
por: Emmanuel, Anton, et al.
Publicado: (2016)

A case-control study of risk factors for wound infection in a colorectal unit
por: Power, K, et al.
Publicado: (2014)

Size of metastatic deposits affects prognosis in patients undergoing pulmonary metastectomy for colorectal cancer
por: Javed, MA, et al.
Publicado: (2014)

Associations between diagnostic pathways and care experience in colorectal cancer: evidence from patient-reported data
por: Salika, Theodosia, et al.
Publicado: (2018)

An urgent need to institute COVID-19 testing in patients with IBD experiencing flares
por: Quraishi, Mohammed Nabil, et al.
Publicado: (2020)

Diagnosis and management of bile acid diarrhoea: a survey of UK expert opinion and practice
por: Walters, Julian R F, et al.
Publicado: (2019)

Faecal immunochemical testing (FIT) in symptomatic patients: what are we missing?
por: Farrugia, Alexia, et al.
Publicado: (2019)

Clinico‐metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases
por: Bohlok, Ali, et al.
Publicado: (2021)

The patient perspective on the preoperative colorectal cancer care pathway and preparedness for surgery and postoperative recovery—a qualitative interview study
por: Cuijpers, Anne C. M., et al.
Publicado: (2022)

Is increasing nodal count associated with improved recurrence‐free and overall survival following standard right hemicolectomy for colon cancer?
por: Hayes, Ian P., et al.
Publicado: (2022)

T‐stage downstaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy is not associated with reduced recurrence after adjusting for tumour characteristics
por: Hayes, Ian P., et al.
Publicado: (2022)

Evaluating the longitudinal effect of colorectal surgery on health‐related quality of life in patients with colorectal cancer
por: Reudink, Muriël, et al.
Publicado: (2021)

Inflammatory bowel disease negatively impacts household and family life
por: Paulides, Emma, et al.
Publicado: (2021)

Outcomes after repeat hepatectomy for colorectal liver metastases from the colorectal liver operative metastasis international collaborative (COLOMIC)
por: Valenzuela, Cristian D., et al.
Publicado: (2022)

Aerobic fitness and muscle density play a vital role in postoperative complications in colorectal cancer surgery
por: Cuijpers, Anne C. M., et al.
Publicado: (2022)

Disease activity, burden and suffering in patients with ulcerative colitis in the UK cohort recruited into the global ICONIC study
por: Bhala, Neeraj, et al.
Publicado: (2022)

Peritoneal recurrence after resection for Stage I–III colorectal cancer: A population analysis
por: Aiken, Taylor, et al.
Publicado: (2022)

A palliative stent for an acute large bowel obstruction—A video vignette
por: Edwards Murphy, Amy, et al.
Publicado: (2022)

Race, age, and sex differences on the influence of obesity on colorectal cancer sidedness and mortality: A national cross‐sectional study
por: Ulanja, Mark B., et al.
Publicado: (2022)

Establishing key performance indicators for inflammatory bowel disease in the UK
por: Quraishi, Mohammed Nabil, et al.
Publicado: (2023)

Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction
por: Normatov, Inessa, et al.
Publicado: (2021)

Infliximab for Crohn’s Disease: More Than 13 Years of Real-world Experience
por: Lichtenstein, Gary R, et al.
Publicado: (2018)

Identifying the need for a UK colorectal cancer screening programme for patients with cystic fibrosis (CF): 10-year retrospective review of colonoscopy and colorectal cancer outcomes at a single CF centre
por: Sapru, Karuna, et al.
Publicado: (2023)

2010 SSO John Wayne Clinical Research Lecture: Rectal Cancer Outcome Improvements in Europe: Population-Based Outcome Registrations will Conquer the World
por: van Gijn, W., et al.
Publicado: (2010)

Infliximab to treat Crohn’s disease: an update
por: Cottone, M, et al.
Publicado: (2011)

Lymph Node Negative Colorectal Cancers with Isolated Tumor Deposits Should Be Classified and Treated As Stage III
por: Belt, E. J. Th., et al.
Publicado: (2010)

Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn’s disease in China
por: Shi, Ji-Hao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_404dob86e5dcisd3logmhsisr6